Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Interest & Investment Income (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Interest & Investment Income for 10 consecutive years, with $552000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 47.99% to $552000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 88.4% increase, with the full-year FY2025 number at $2.1 million, up 88.4% from a year prior.
  • Interest & Investment Income was $552000.0 for Q4 2025 at Niagen Bioscience, down from $564000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $564000.0 in Q3 2025 to a low of $188000.0 in Q3 2023.
  • A 3-year average of $372600.0 and a median of $327500.0 in 2023 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: skyrocketed 32.27% in 2024, then surged 129.05% in 2025.
  • Niagen Bioscience's Interest & Investment Income stood at $282000.0 in 2023, then skyrocketed by 32.27% to $373000.0 in 2024, then surged by 47.99% to $552000.0 in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Interest & Investment Income are $552000.0 (Q4 2025), $564000.0 (Q3 2025), and $552000.0 (Q2 2025).